Document is current
Any future updates will be listed below
-
Authors
Finbloom, Joel A. https://orcid.org/0000-0003-0411-1755
Huynh, Cindy
Huang, Xiao https://orcid.org/0000-0001-7733-9094
Desai, Tejal A. https://orcid.org/0000-0003-3409-9208
- License Information
-
More Information
Article History
Accepted: 15 November 2022
First Online: 26 January 2023
Competing interests
: T.A.D. is a scientific founder of Oculinea, Encellin, VasaRx, and Biothelium and received grant funding from Kimberly Clarke and Roche related to the work described herein. The remaining authors declare no competing interests.
